NLS Pharmaceutics AG Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
05/15/2024 | Q4 2023 | -$0.12 | $0 | |||
06/29/2023 | Q2 2023 | -$0.20 | $0 | |||
05/05/2023 | Q4 2022 | -$0.29 | $0 | |||
10/11/2022 | Q2 2022 | -$0.54 | $0 | |||
03/24/2022 | Q4 2021 | -$0.50 | $0 | |||
09/28/2021 | Q2 2021 | -$0.42 | $0 | |||
05/14/2021 | Q4 2020 | -$0.34 | $0 | |||
06/29/2020 | Q2 2020 | -$0.11 | $0 | |||
12/30/2019 | Q4 2019 | -$0.18 | $0 | |||
06/29/2019 | Q2 2019 | -$0.31 | $0 | |||
12/30/2018 | Q4 2018 | -$0.48 | $0 | |||
06/29/2018 | Q2 2018 | -$0.34 | $0 | |||
03/30/2018 | Q1 2018 | -$0.12 | $0 | |||
06/29/2017 | Q2 2017 | -$0.16 | $0 | |||
03/30/2017 | Q1 2017 | -$0.16 | $0 |
NLS Pharmaceutics AG Earnings: Frequently Asked Questions
-
How can I listen to NLS Pharmaceutics AG's earnings conference call?
The conference call for NLS Pharmaceutics AG's latest earnings report can be listened to online.
-
How can I read NLS Pharmaceutics AG's conference call transcript?
The conference call transcript for NLS Pharmaceutics AG's latest earnings report can be read online.
-
How much profit does NLS Pharmaceutics AG generate each year?
NLS Pharmaceutics AG (:NLSPW) has a recorded net income of $0. NLS Pharmaceutics AG has generated $-0.32 earnings per share over the last four quarters.
-
What is NLS Pharmaceutics AG's price-to-earnings ratio?
NLS Pharmaceutics AG (:NLSPW) has a price-to-earnings ratio of -13.05 and price/earnings-to-growth ratio is -0.21.